Cargando…
ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities
The success of orthotopic liver transplantation as a life-saving treatment has led to new indications and a greater competition for organ grafts. Pediatric patients with acute liver-related crises can benefit from orthotopic liver transplantation, but organ availability in the limited time can be a...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722564/ https://www.ncbi.nlm.nih.gov/pubmed/36479277 http://dx.doi.org/10.1097/TXD.0000000000001353 |
_version_ | 1784843991338975232 |
---|---|
author | Shagrani, Mohammad Kumar, Kishwer Baker, Alastair Al-Awwami, Moheeb Alhussaini, Hussa Almanea, Hadeel Alhumaidan, Hind Iorio, Raffaele Al-Khabbaz, Hana Burdelski, Martin Troisi, Roberto I. Broering, Dieter C. |
author_facet | Shagrani, Mohammad Kumar, Kishwer Baker, Alastair Al-Awwami, Moheeb Alhussaini, Hussa Almanea, Hadeel Alhumaidan, Hind Iorio, Raffaele Al-Khabbaz, Hana Burdelski, Martin Troisi, Roberto I. Broering, Dieter C. |
author_sort | Shagrani, Mohammad |
collection | PubMed |
description | The success of orthotopic liver transplantation as a life-saving treatment has led to new indications and a greater competition for organ grafts. Pediatric patients with acute liver-related crises can benefit from orthotopic liver transplantation, but organ availability in the limited time can be a major obstacle. Crossing ABO blood group barriers could increase the organs available to such patients METHODS. From November 2010 to June 2015, 176 children aged 0.2−to18 y were transplanted in the King Faisal Specialist Hospital and Research Center. Out of those, 19 children were transplanted across blood group barriers (ABO incompatible). The underlying diseases were biliary atresia (n = 6); progressive familial intrahepatic cholestasis type 2 (n = 4); Crigler-Najjar syndrome (n = 3); hepatoblastoma (n = 2); and urea cycle disorder, Caroli disease, cryptogenic cirrhosis, and neonatal sclerosing cholangitis (n = 1 each). Immunosuppression consisted of basiliximab, mycophenolate, tacrolimus, and steroids. Pretransplant prophylactic plasmapheresis, high-dose immunoglobulins, and rituximab were not administered. RESULTS. The grafts were from living donors (n = 17) and deceased donors (n = 2). Living donor morbidity was nil. The recipient median age was 21 mo (5−70 mo). After a median follow-up of 44 mo, 2 recipients (10%) died because of sepsis, 1 because of uncontrolled acute myeloid leukemia. The overall rejection rate was 7%, and no grafts were lost because of antibody-mediated rejection (AMR). HLA matching was 3.8 of 6 (A, B, DR), and there were 2 patients presented with acute cellular rejection, 1 patient with AMR, and 1 patient with biliary strictures. CONCLUSIONS. ABO incompatible liver transplantation is a feasible and life-saving option even with antibody and B-cell depletion-free protocol without increasing the risks for AMR. We speculate that this excellent result is most likely because of presence of relatively low titer ABO isoagglutinins and the high HLA match compatibility caused by habit of longstanding interfamilial marriages as typical of Saudi Arabia. |
format | Online Article Text |
id | pubmed-9722564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-97225642022-12-06 ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities Shagrani, Mohammad Kumar, Kishwer Baker, Alastair Al-Awwami, Moheeb Alhussaini, Hussa Almanea, Hadeel Alhumaidan, Hind Iorio, Raffaele Al-Khabbaz, Hana Burdelski, Martin Troisi, Roberto I. Broering, Dieter C. Transplant Direct Liver Transplantation The success of orthotopic liver transplantation as a life-saving treatment has led to new indications and a greater competition for organ grafts. Pediatric patients with acute liver-related crises can benefit from orthotopic liver transplantation, but organ availability in the limited time can be a major obstacle. Crossing ABO blood group barriers could increase the organs available to such patients METHODS. From November 2010 to June 2015, 176 children aged 0.2−to18 y were transplanted in the King Faisal Specialist Hospital and Research Center. Out of those, 19 children were transplanted across blood group barriers (ABO incompatible). The underlying diseases were biliary atresia (n = 6); progressive familial intrahepatic cholestasis type 2 (n = 4); Crigler-Najjar syndrome (n = 3); hepatoblastoma (n = 2); and urea cycle disorder, Caroli disease, cryptogenic cirrhosis, and neonatal sclerosing cholangitis (n = 1 each). Immunosuppression consisted of basiliximab, mycophenolate, tacrolimus, and steroids. Pretransplant prophylactic plasmapheresis, high-dose immunoglobulins, and rituximab were not administered. RESULTS. The grafts were from living donors (n = 17) and deceased donors (n = 2). Living donor morbidity was nil. The recipient median age was 21 mo (5−70 mo). After a median follow-up of 44 mo, 2 recipients (10%) died because of sepsis, 1 because of uncontrolled acute myeloid leukemia. The overall rejection rate was 7%, and no grafts were lost because of antibody-mediated rejection (AMR). HLA matching was 3.8 of 6 (A, B, DR), and there were 2 patients presented with acute cellular rejection, 1 patient with AMR, and 1 patient with biliary strictures. CONCLUSIONS. ABO incompatible liver transplantation is a feasible and life-saving option even with antibody and B-cell depletion-free protocol without increasing the risks for AMR. We speculate that this excellent result is most likely because of presence of relatively low titer ABO isoagglutinins and the high HLA match compatibility caused by habit of longstanding interfamilial marriages as typical of Saudi Arabia. Lippincott Williams & Wilkins 2022-11-04 /pmc/articles/PMC9722564/ /pubmed/36479277 http://dx.doi.org/10.1097/TXD.0000000000001353 Text en Copyright © 2022 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Liver Transplantation Shagrani, Mohammad Kumar, Kishwer Baker, Alastair Al-Awwami, Moheeb Alhussaini, Hussa Almanea, Hadeel Alhumaidan, Hind Iorio, Raffaele Al-Khabbaz, Hana Burdelski, Martin Troisi, Roberto I. Broering, Dieter C. ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities |
title | ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities |
title_full | ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities |
title_fullStr | ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities |
title_full_unstemmed | ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities |
title_short | ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities |
title_sort | abo-incompatible pediatric liver transplantation with antibody and b-cell depletion-free immunosuppressive protocol in high consanguinity communities |
topic | Liver Transplantation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722564/ https://www.ncbi.nlm.nih.gov/pubmed/36479277 http://dx.doi.org/10.1097/TXD.0000000000001353 |
work_keys_str_mv | AT shagranimohammad aboincompatiblepediatriclivertransplantationwithantibodyandbcelldepletionfreeimmunosuppressiveprotocolinhighconsanguinitycommunities AT kumarkishwer aboincompatiblepediatriclivertransplantationwithantibodyandbcelldepletionfreeimmunosuppressiveprotocolinhighconsanguinitycommunities AT bakeralastair aboincompatiblepediatriclivertransplantationwithantibodyandbcelldepletionfreeimmunosuppressiveprotocolinhighconsanguinitycommunities AT alawwamimoheeb aboincompatiblepediatriclivertransplantationwithantibodyandbcelldepletionfreeimmunosuppressiveprotocolinhighconsanguinitycommunities AT alhussainihussa aboincompatiblepediatriclivertransplantationwithantibodyandbcelldepletionfreeimmunosuppressiveprotocolinhighconsanguinitycommunities AT almaneahadeel aboincompatiblepediatriclivertransplantationwithantibodyandbcelldepletionfreeimmunosuppressiveprotocolinhighconsanguinitycommunities AT alhumaidanhind aboincompatiblepediatriclivertransplantationwithantibodyandbcelldepletionfreeimmunosuppressiveprotocolinhighconsanguinitycommunities AT iorioraffaele aboincompatiblepediatriclivertransplantationwithantibodyandbcelldepletionfreeimmunosuppressiveprotocolinhighconsanguinitycommunities AT alkhabbazhana aboincompatiblepediatriclivertransplantationwithantibodyandbcelldepletionfreeimmunosuppressiveprotocolinhighconsanguinitycommunities AT burdelskimartin aboincompatiblepediatriclivertransplantationwithantibodyandbcelldepletionfreeimmunosuppressiveprotocolinhighconsanguinitycommunities AT troisirobertoi aboincompatiblepediatriclivertransplantationwithantibodyandbcelldepletionfreeimmunosuppressiveprotocolinhighconsanguinitycommunities AT broeringdieterc aboincompatiblepediatriclivertransplantationwithantibodyandbcelldepletionfreeimmunosuppressiveprotocolinhighconsanguinitycommunities |